로딩 중…
지수 로딩 중…
Regencell Bioscience Holdings Limited
RGC· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
HK
HK$6.13-0.81%
2026-08-03
Financials
Valuation Metrics
Regencell Bioscience Holdings Limited's Market Cap is $3.03B. At end of 2025 it was $10.38B. Ranked #1756 of 3,112 in US market (top 56%), #627 of 1,445 on NASDAQ (top 43%), #105 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 39%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.03B | US#1,756/3,112 Sec#105/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-4M | US—/3,112 Sec—/269 |
| Total Assets | $6M | US#3,068/3,112 Sec#271/269 |
| Net Assets | $5M | US#3,001/3,112 Sec#261/269 |
| Value | ||
| P/B | 623.67x | US#2,976/3,112 Sec#262/269 |
| FCF Yield | -0.11% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -73.75% | US#2,815/3,112 Sec#207/269 |
| ROA | -62.27% | US#3,007/3,112 Sec#240/269 |
| Financial Health | ||
| Debt Ratio | 18.42% | US#199/3,112 Sec#74/269 |
| Total Debt | $544415.00 | US#2,950/3,112 Sec#258/269 |
| FCF | $-3M | US#2,291/3,112 Sec#88/269 |
| Cash | $2M | US#3,029/3,112 Sec#269/269 |
| Current Ratio | 7.39x | US#320/3,112 Sec#105/269 |
| Performance | ||
| 1Y Return | -52.74% | US#3,013/3,112 Sec#252/269 |
| 1M Return | -3.77% | US#2,118/3,112 Sec#112/269 |
| From 52W High | -91.12% | US#3,115/3,112 Sec#270/269 |
| 1Y MDD | -90.96% | US#3,111/3,112 Sec#270/269 |
| Trading | ||
| Volume | 290,861 shares | US#2,432/3,112 Sec#237/269 |
| Trading Value | $2M | US#2,940/3,112 Sec#247/269 |
| Per Share | ||
| EPS | $-0.01 | US—/3,112 Sec—/269 |
| BPS | $0.01 | US#2,724/3,112 Sec#233/269 |